英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
645752查看　645752　在百度字典中的解释百度英翻中〔查看〕
645752查看　645752　在Google字典中的解释Google英翻中〔查看〕
645752查看　645752　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Durvalumab - Wikipedia
    In November 2025, the US FDA approved durvalumab with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT chemotherapy) as neoadjuvant and adjuvant treatment, followed by single agent durvalumab, for adults with resectable gastric or gastroesophageal junction adenocarcinoma
  • Durvalumab: Uses, Dosage, Side Effects, Warnings - Drugs. com
    Durvalumab is an immune checkpoint inhibitor that targets the PD-L1 protein on cancer cells, helping the immune system more effectively recognize and attack cancer cells
  • Durvalumab (intravenous route) - Side effects uses
    Durvalumab injection is used in combination with platinum-containing chemotherapy before surgery and then used alone after surgery in patients with non-small cell lung cancer (NSCLC) which can be removed by surgery and do not have an abnormal EGFR or ALK gene
  • label - Food and Drug Administration
    IMFINZI is indicated for the treatment of adult patients with unresectable Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based
  • Imfinzi (durvalumab): Uses, Side Effects, Interactions . . . - WebMD
    Overview: Imfinzi is used to treat various types of cancers It is a type of immunotherapy that works by helping your immune system find and attack cancer cells Common side effects include cough,
  • Immunotherapy for Certain Cancers - IMFINZI® (durvalumab)
    IMFINZI® (durvalumab) is an immunotherapy approved to treat patients with NSCLC, SCLC, GC GEJC, uHCC, BTC, MIBC and advanced or recurrent dMMR
  • Durvalumab - Chemocare
    DURVALUMAB (dur VAL ue mab) treats some types of cancer It works by helping your immune system slow or stop the spread of cancer cells It is a monoclonal antibody This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions COMMON BRAND NAME (S): IMFINZI
  • Durvalumab - NCI - National Cancer Institute
    This page contains brief information about durvalumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials
  • Durvalumab (Imfinzi) | Cancer information | Cancer Research UK
    Durvalumab is a type of immunotherapy It is a treatment for lung cancer Find out about how you have it, possible side effects and other important information
  • Durvalumab (Imfinzi®) - Macmillan Cancer Support
    Durvalumab is also called Imfinzi ® It is a type of immunotherapy drug called a checkpoint inhibitor Durvalumab is used to treat non-small cell lung cancer (NSCLC) It may sometimes be used to treat other cancers It is best to read this information with our general information about immunotherapy drug and the type of cancer you have





中文字典-英文字典  2005-2009